Preparation method and application of probiotic-Synechocystis aggregates for oral probiotic delivery
By modifying synesophobia cells to form probiotic-sychozoa aggregates, the problem of reduced activity of probiotics in the gastrointestinal environment is solved, efficient colonization of probiotics and regulation of intestinal bacteria is achieved, and the therapeutic effect is significantly improved , provides new treatment options for inflammatory bowel disease.
Patent Information
- Application Number
- CN202311320645.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-10-12
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2043-10-12
AI Technical Summary
After oral administration, probiotics are susceptible to damage by gastric acid, bile salts and digestive enzymes. Intestinal peristalsis and immune system clearance lead to reduced activity, resulting in low intestinal colonization efficiency, limiting the therapeutic effect of oral probiotic therapy.
By modifying Synecytidal cells using polydiallyldimethylammonium chloride (PDADMAC), forming a bionic silicide protein layer, and encapsulating probiotics in Synecytidal aggregates, the intercellular induced by sodium silicate solution Aggregate to form probiotic-Cytocytium aggregates with uniform particle size, enhancing the tolerance and colonization ability of probiotics.
It significantly improves the growth and colonization efficiency of probiotics, restores and rebuilds the intestinal barrier, regulates the intestinal flora, has good anti-inflammatory effects, effectively prevents and treats colitis and inflammatory bowel diseases, and has simple preparation method and low production costs.
Smart Images

Figure CN117243919B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of pharmaceutical preparations, and in particular to a preparation method and application of a probiotic-Synechocystis aggregate for oral probiotic delivery. Background Art
[0002] In recent years, with the continuous deepening of intestinal flora research, more and more evidence shows that intestinal microbiota is essential for maintaining the intestinal homeostasis and physical health of the host. Oral delivery of probiotics can maintain the normal health of the human body by directly intervening in the composition of the intestinal microbiota, inhibiting the colonization of foreign pathogens, maintaining the balance of the body's immune system and maintaining the homeostasis of the intestinal mucosa. Due to its significant advantages and therapeutic effects, it is widely used in the clinical treatment of various diseases. However, probiotics will encounter various physiological challenges after oral administration, such as the destruction of gastric acid, bile salts and digestive enzymes, the emptying effect caused by intestinal peristalsis, the clearance of the body's immune system and the competition of intestinal native flora. These challenges reduce the number of active probiotics that can safely reach the intestine and colonize for a long time, weakening the therapeutic effect of oral probiotic therapy and limiting the application of probiotics in oral drug delivery systems. In nature, organisms can construct many organic-inorganic composite materials with complex and fine structures and excellent biological properties. This phenomenon is called biomineralization. Diatoms are a typical example. Algal cells can form a finely structured nano-silica shell on the surface of the original cells through biosilicon mineralization, which can provide mechanical protection and photon response for themselves. Studies have shown that polydiallyldimethylammonium chloride (PDADMAC) molecules can be used as biomimetic silicified proteins adsorbed on the surface of Chlorella. The modified Chlorella can spontaneously form aggregates after being resuspended in a sodium silicate solution. Compared with the Chlorella before modification, the aggregates improve the protection of Chlorella against light stress.
[0003] Synechocystis cells were modified with polydiallyldimethylammonium chloride (PDADMAC) molecules. PDADMAC can form a biomimetic siliconized protein layer on the surface of Synechocystis cells. The biomimetic modified Synechocystis cells were resuspended in Na2SiO3 solution to induce the self-aggregation behavior between Synechocystis cells to form aggregates. Among them, the Synechocystis cells were tightly adhered together by amorphous silica. By adding Bacillus subtilis during the aggregation process, Bacillus subtilis cells can be encapsulated in Synechocystis aggregates, thereby preparing an aggregate based on Synechocystis and probiotics. First, the system can protect probiotics from damage by the harsh physiological environment of the gastrointestinal tract (such as gastric acid, bile salts and digestive enzymes), so that a sufficient amount of active probiotics can reach the colon. Secondly, Synechocystis can be decomposed by digestive enzymes secreted by intestinal microbiota, and as a prebiotic, it provides energy for the growth and colonization of probiotics, thereby better regulating the intestinal microbiota, inhibiting the colonization of foreign pathogens, maintaining the balance of the body's immune system and maintaining the homeostasis of the intestinal mucosa. This probiotic delivery system, which is constructed by using probiotics and Synechocystis to form aggregates, has significant therapeutic and preventive effects on colitis, but has not been publicly reported so far. Summary of the invention
[0004] In view of the above situation, in order to overcome the defects of the prior art, the purpose of the present invention is to provide a preparation method and application of a probiotic delivery system constructed based on the aggregates formed by probiotics and Synechocystis, which can effectively solve the problem of inactivation or reduced activity of probiotics after oral administration after stomach administration caused by various physiological challenges, thereby leading to low intestinal colonization efficiency, so as to promote the growth and proliferation of probiotics, restore and rebuild the intestinal barrier, regulate the intestinal flora, and thus achieve effective prevention and treatment of colitis.
[0005] The technical solution provided by the present invention is a method for preparing probiotic-Synechocystis aggregates for oral probiotic delivery. First, probiotics and Synechocystis are cultured, and the Synechocystis is biomimetic silicified by cationic polyelectrolyte polydiallyldimethylammonium chloride (PDADMAC). Then, Bacillus subtilis and the modified Synechocystis are successively resuspended in a sodium silicate solution and co-incubated. The Synechocystis cells can wrap up the probiotic cells during the spontaneous aggregation process, so as to prepare probiotic-Synechocystis aggregates with uniform particle size and stable properties. The specific steps are as follows:
[0006] (1) Cultivating probiotics: inoculate the probiotic freeze-dried powder into a nutrient broth liquid culture medium, place it in a constant temperature incubator at 37-38°C, and culture it at a shaking speed of 180-200 r / min. When the proliferating reaches the logarithmic growth phase, collect the bacterial liquid for later use;
[0007] The probiotics are Bacillus subtilis, Escherichia coli or Lactobacillus reuteri;
[0008] The nutrient broth liquid culture medium: 0.3g beef extract, 1g peptone and 0.5g NaCl are dissolved in 90mL distilled water, the pH is adjusted to 7.0-7.4, the volume is fixed to 100mL, sterilized at 121°C for 30min, and cooled to room temperature;
[0009] (2) Cultivating Synechocystis: Inoculate the Synechocystis algae in a liquid culture medium, place it in a constant temperature and light incubator at 25-30°C, and culture it under conditions of 12 hours of light and 12 hours of darkness to simulate day and night alternation. When the Synechocystis algae proliferates to the logarithmic phase, collect the algae liquid for later use;
[0010] The liquid culture medium: 15g NaNO3, 2g K2HPO4, 3.75g MgSO4·7H2O, 1.8g CaCl2·2H2O, 0.3g citric acid, 0.3g ferric citrate ammonium, 0.05g EDTANa2, 1g Na2CO3, 0.286g H3BO3, 0.186g MnCl2·4H2O, 0.022g ZnSO4·7H2O, 0.039g Na2Mo4.2H2O, 0.008g CuSO4. 5H2O, 0.005g Co(NO3)2.6 H2O are dissolved in 50L ultrapure water, and filtered with a 0.22 micron filter membrane for sterilization to obtain the culture medium;
[0011] (3) Preparation of biomimetic modified Synechocystis (SP-PDADMAC): Take 5-15 mL of the Synechocystis solution obtained in step (2) and the algal cell concentration is OD 680 =0.8~1, centrifuge at 5000g for 5~10min, collect the precipitate, wash 3 times with 5~20mL NaCl solution to remove the residual culture medium, and obtain Synechocystis cells; the surface of Synechocystis cells is negatively charged and can be modified by positive charge, and the cationic polyelectrolyte polydiallyldimethylammonium chloride (PDADMAC) molecule contains a positively charged quaternary amine, which is modified on the surface of Synechocystis to modify it; take Synechocystis cells, resuspend them with 5~50ml PDADMAC solution, place them in an incubator, and incubate them at a shaking speed of 80~100r / min for 30~60min to allow PDADMAC to fully adsorb on the surface of Synechocystis cells, centrifuge at 5000g for 5~10min, collect the precipitate, wash it with ultrapure water, and resuspend it to 1~2mL to obtain biomimetic modified Synechocystis (SP-PDADMAC);
[0012] The NaCl solution: 0.9 g NaCl was dissolved in 100 mL ultrapure water and mixed thoroughly to obtain a 0.9% NaCl solution;
[0013] The PDADMAC solution: 1-5 mL of 20% PDADMAC by weight is dissolved in 245 mL of sterile saline and mixed thoroughly to obtain a 1 g / L PDADMAC solution;
[0014] (4) Preparation of probiotic bacteria-Synechocystis aggregates (ASP@BS): 1-3 mL of the probiotic bacterial solution obtained in step (1) with a bacterial solution concentration of OD600 = 0.8-1 was taken and centrifuged at 5000 g for 5-10 min. The precipitate was collected and washed three times with 5-20 mL of NaCl solution to remove residual culture medium to obtain probiotic cells; the obtained probiotic cells were resuspended in 5-20 mL of sodium silicate solution, and then the biomimetic modified Synechocystis (SP-PDADMAC) solution obtained in step (3) was added dropwise to the sodium silicate solution, placed in a round-bottom flask, and stirred with a magnetic stirrer for 30-60 min to obtain probiotic bacteria-Synechocystis aggregates;
[0015] The sodium silicate solution is prepared by dissolving 5-20 mg Na2SiO3 in 9 mL PBS phosphate buffer, adjusting the pH to 7-7.4 with 0.1 M HCl solution, and then making the volume to 10 mL.
[0016] The probiotic delivery system based on the formation of probiotics and Synechocystis prepared by the method has high tolerance to harsh physiological environments such as the gastrointestinal tract, and can effectively solve the problem of reduced number and activity of probiotics caused by various gastrointestinal physiological challenges, significantly promote the colonization, growth and reproduction of probiotics, restore and rebuild the intestinal barrier, regulate the intestinal flora, and improve the efficacy of probiotic therapy. By inhibiting the expression of pro-inflammatory factors such as IL-1β, TNF-α, IL-6, and promoting the expression of anti-inflammatory factors such as IL-10 and TGF-β, it exerts a good anti-inflammatory effect, and has the advantages of efficiently passing through the gastric acid environment, achieving rapid colonization and proliferation in the colon, restoring and rebuilding the integrity of the intestinal barrier, maintaining intestinal mucosal homeostasis, and increasing the richness and diversity of the intestinal flora, thereby achieving effective prevention and treatment of inflammatory bowel disease and related colitis, and realizing the application in the preparation of drugs for the prevention and treatment of inflammatory bowel disease and related colitis. The preparation method is simple and the production cost is low. By incorporating different types of probiotics into the mineralization process, protective delivery of different types of probiotics can be achieved, which can not only protect the probiotics from damage by gastric acid, but also promote the exponential growth and rapid colonization of probiotics in the intestine, regulate the intestinal flora, and enhance the intestinal barrier. It provides new technical support for the treatment of inflammatory bowel disease and is an innovation in oral microecological preparations with huge economic and social benefits. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1 This is a scanning electron microscope image of the probiotic-Synechocystis aggregate of the present invention.
[0018] Figure 2 It is a curve diagram of the colonization quantity of probiotics in different groups of the present invention.
[0019] Figure 3 The blood biochemistry and blood routine data of different groups of mice in the present invention are shown in FIG.
[0020] Figure 4 The figure is a curve diagram of body weight changes of colitis mice after treatment in different groups of the present invention. DETAILED DESCRIPTION
[0021] The specific implementation modes of the present invention are further described below by way of examples.
[0022] The present invention can be specifically implemented by the following examples. Example 1
[0023] The present invention provides a method for preparing a probiotic-Synechocystis aggregate for oral probiotic delivery, comprising the following steps:
[0024] (1) Cultivating probiotics: inoculate the freeze-dried powder of Bacillus subtilis into a nutrient broth liquid culture medium, place it in a constant temperature incubator at 37°C, and culture it at a shaking speed of 200 r / min. When the proliferation reaches the logarithmic growth phase, collect the bacterial liquid for later use;
[0025] (2) Cultivating Synechocystis: inoculate the Synechocystis algae in a liquid culture medium, place it in a constant temperature and light incubator at 25°C, and culture it under conditions of 12 hours of light and 12 hours of darkness to simulate day and night alternation. When the Synechocystis algae proliferates to the logarithmic phase, collect the algae liquid for later use;
[0026] (3) Preparation of biomimetic modified Synechocystis (SP-PDADMAC): Take 5 mL of the Synechocystis solution obtained in step (2) and the algal cell concentration is OD 680 =1, centrifuged at 5000g for 5min, collected the precipitate, washed 3 times with 20mL NaCl solution to remove the residual culture medium, and obtained Synechocystis cells; the surface of Synechocystis cells is negatively charged and can be modified by positive charges. The cationic polyelectrolyte polydiallyldimethylammonium chloride (PDADMAC) molecule contains a positively charged quaternary amine, which is modified on the surface of Synechocystis to modify it; Synechocystis cells were taken, resuspended with 10mL PDADMAC solution, placed in an incubator, and incubated at an oscillation speed of 80r / min for 60min to allow PDADMAC to fully adsorb on the surface of Synechocystis cells, centrifuged at 5000g for 5min, collected the precipitate, washed with ultrapure water, and resuspended to 1mL to obtain biomimetic modified Synechocystis (SP-PDADMAC);
[0027] (4) Preparation of Bacillus subtilis-Synechocystis aggregates (ASP@BS): 1 mL of the Bacillus subtilis bacterial solution obtained in step (1) with a bacterial solution concentration of OD600 = 1 was taken and centrifuged at 5000 g for 5 min. The precipitate was collected and washed three times with 20 mL of NaCl solution to remove residual culture medium to obtain Bacillus subtilis cells; the obtained Bacillus subtilis cells were resuspended in 5 mL of sodium silicate solution, and then the biomimetic modified Synechocystis (SP-PDADMAC) solution obtained in step (3) was added dropwise to the sodium silicate solution, placed in a round-bottom flask, and stirred with a magnetic stirrer for 40 min to obtain Bacillus subtilis-Synechocystis aggregates. Example 2
[0028] The present invention provides a method for preparing a probiotic-Synechocystis aggregate for oral probiotic delivery, comprising the following steps:
[0029] (1) Cultivating probiotics: inoculate the freeze-dried powder of Escherichia coli into a nutrient broth liquid culture medium, place it in a constant temperature incubator at 37°C, and culture it at a shaking speed of 180 r / min. When the proliferation reaches the logarithmic growth phase, collect the bacterial liquid for later use;
[0030] (2) Cultivating Synechocystis: Inoculate the Synechocystis algae in a liquid culture medium, place it in a constant temperature and light incubator at 28°C, and culture it under conditions of 12 hours of light and 12 hours of darkness to simulate day and night alternation. When the Synechocystis algae proliferates to the logarithmic phase, collect the algae liquid for later use;
[0031] (3) Preparation of biomimetic modified Synechocystis (SP-PDADMAC): Take 10 mL of the Synechocystis solution obtained in step (2) and the algal cell concentration is OD 680 =0.9, centrifuged at 5000g for 8min, collected the precipitate, washed 3 times with 15mL NaCl solution to remove the residual culture medium, and obtained Synechocystis cells; the surface of Synechocystis cells is negatively charged and can be modified by positive charges, and the cationic polyelectrolyte polydiallyldimethylammonium chloride (PDADMAC) molecules contain positively charged quaternary amines, which are modified on the surface of Synechocystis to modify it; Synechocystis cells were taken, resuspended with 50mL PDADMAC solution, placed in an incubator, and incubated at a shaking speed of 90r / min for 45min to allow PDADMAC to fully adsorb on the surface of Synechocystis cells, centrifuged at 5000g for 8min, collected the precipitate, washed with ultrapure water, and resuspended to 1mL to obtain biomimetic modified Synechocystis (SP-PDADMAC);
[0032] (4) Preparation of probiotic bacteria-Synechocystis aggregates (ASP@EcN): 2 mL of the Escherichia coli bacterial solution obtained in step (1) with a bacterial solution concentration of OD600 = 0.9 was taken and centrifuged at 5000 g for 8 min. The precipitate was collected and washed three times with 15 mL of NaCl solution to remove residual culture medium to obtain Escherichia coli cells. The obtained Escherichia coli cells were resuspended in 5 mL of sodium silicate solution. Subsequently, the biomimetic modified Synechocystis (SP-PDADMAC) solution obtained in step (3) was added dropwise to the sodium silicate solution, and the mixture was placed in a round-bottom flask and stirred with a magnetic stirrer for 30 min to obtain Escherichia coli-Synechocystis aggregates. Example 3
[0033] The present invention provides a method for preparing a probiotic-Synechocystis aggregate for oral probiotic delivery, comprising the following steps:
[0034] (1) Cultivating probiotics: inoculate the freeze-dried powder of Lactobacillus reuteri into a nutrient broth liquid culture medium, place it in a constant temperature incubator at 38°C, and culture it at a shaking speed of 180 r / min. When the proliferating reaches the logarithmic growth phase, collect the bacterial liquid for later use;
[0035] (2) Cultivating Synechocystis: Inoculate the Synechocystis algae in a liquid culture medium, place it in a constant temperature and light incubator at 30°C, and culture it under conditions of 12 hours of light and 12 hours of darkness to simulate day and night alternation. When the Synechocystis algae proliferates to the logarithmic phase, collect the algae liquid for later use;
[0036] (3) Preparation of biomimetic modified Synechocystis (SP-PDADMAC): Take 15 mL of the Synechocystis solution obtained in step (2) and the algal cell concentration is OD 680 =0.8, centrifuged at 5000g for 10min, collected the precipitate, washed 3 times with 10mL NaCl solution to remove the residual culture medium, and obtained Synechocystis cells; the surface of Synechocystis cells is negatively charged and can be modified by positive charges, and the cationic polyelectrolyte polydiallyldimethylammonium chloride (PDADMAC) molecules contain positively charged quaternary amines, which are modified on the surface of Synechocystis to modify it; Synechocystis cells were taken, resuspended with 30ml PDADMAC solution, placed in an incubator, and incubated at an oscillation speed of 100r / min for 35min to allow PDADMAC to fully adsorb on the surface of Synechocystis cells, centrifuged at 5000g for 5min, collected the precipitate, washed with ultrapure water, and resuspended to 2mL to obtain biomimetic modified Synechocystis (SP-PDADMAC);
[0037] (4) Preparation of probiotic bacteria-Synechocystis aggregates (ASP@LR): 3 mL of the Lactobacillus reuteri culture obtained in step (1) with a culture concentration of OD600 = 0.8 was taken and centrifuged at 5000 g for 10 min. The precipitate was collected and washed three times with 10 mL of NaCl solution to remove residual culture medium to obtain Lactobacillus reuteri cells; the obtained Lactobacillus reuteri cells were resuspended in 10 mL of sodium silicate solution, and then the biomimetic modified Synechocystis (SP-PDADMAC) solution obtained in step (3) was added dropwise to the sodium silicate solution, placed in a round-bottom flask, and stirred with a magnetic stirrer for 50 min to obtain Lactobacillus reuteri-Synechocystis aggregates.
[0038] Use of the probiotic-Synechocystis aggregates prepared by the methods shown in Examples 1-3 in the preparation of drugs for preventing and treating inflammatory bowel disease and related colitis.
[0039] The aggregates formed by probiotics and Synechocystis prepared by the present invention have a simple preparation method, low production cost and are generally applicable to most probiotics. The probiotic-Synechocystis aggregates prepared in the present invention have the advantages of good biocompatibility, high tolerance to the harsh physiological environment of the gastrointestinal tract, and good colitis treatment effect. In addition, due to its rich carbohydrates, Synechocystis can also be used as a prebiotic to provide part of the nutrients for the growth of probiotics and promote the rapid colonization and growth of probiotics. Wrapping different probiotics inside the aggregate can not only protect the activity of probiotics from the influence of the gastric acid environment, but also promote the exponential growth and rapid colonization of probiotics in the intestine, regulate intestinal flora, and enhance the intestinal barrier, providing new technical support for the treatment of inflammatory bowel disease and inflammation-induced cancer. It is not only an innovation in oral microecological preparations, but also has huge economic and social benefits. The present invention has achieved consistent results after repeated tests. The relevant test data are as follows (taking Example 1 as an example):
[0040] First, Bacillus subtilis and Synechocystis cells were cultured, and Synechocystis was biomimetic silicified by cationic polyelectrolyte polydiallyldimethylammonium chloride (PDADMAC). Then, Bacillus subtilis and positively charged Synechocystis were resuspended in sodium silicate solution and co-incubated, and Bacillus subtilis-Synechocystis aggregates with uniform particle size and stable properties were obtained by self-aggregation. The morphology of the aggregates was observed by biological scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM). The results showed that the prepared aggregates were irregular spherical with a particle size of about 100-150μm. The in vitro coating experiment verified that the aggregates could withstand the simulated gastrointestinal environment in vitro and had a high colonization efficiency in vivo.
[0041] Six-week-old C57 mice were randomly divided into three groups: Saline (normal saline), BS (probiotics), and ASP@BS (algae aggregates). Each group contained 1×10 9 Each group of CFUs probiotic preparations was orally administered, and 48 hours after administration, the heart, liver, spleen, lung, kidney and intestinal tissues were taken for H&E staining to analyze their pathological characteristics. In addition, the inflammatory response after administration of each group of preparations was analyzed by blood biochemistry and blood routine indicators. The results showed that no obvious tissue damage and inflammatory response were observed in all groups of mice, indicating that the spore capsid nanomaterials prepared in the present invention and the compositions based on spore capsid nanomaterials and different probiotics are safe for healthy mice.
[0042] First, six-week-old BALB / c mice were fed under the same conditions for one week to reduce the heterogeneity of the intestinal microbial community. Except for the healthy control group, which was given normal drinking water, the mice in other model groups were given 3% DSS drinking water for 7 days. The successful construction of the mouse colon inflammation model was preliminarily determined by the changes in mouse body weight and pathological scores. Subsequently, the mice were randomly divided into 5 groups, namely Normal (normal saline), DSS (dextran sulfate), BS (probiotics), SP (Synechococcus) and ASp@BS (aggregates formed by probiotics and Synechococcus prepared in the present invention). 1×10 9 Each group of CFUs probiotic preparations was orally administered. After 10 days of administration, the weight of mice in the Asp@BS group gradually returned to the level of healthy mice, and the treatment was stopped to evaluate the various indicators of the mice. The results showed that compared with the other treatment groups, the colon length of mice in the Asp@BS group increased significantly, and the disease index (DAI) was lower. Histopathological analysis also showed no obvious inflammatory indicators, indicating that Asp@BS has a significant therapeutic effect on inflammation.
[0043] While experimenting on Example 1, the same experiments were also conducted on other examples, and the same or similar results were obtained, which will not be repeated here.
[0044] The present invention provides a probiotic oral delivery system based on the formation of probiotics and Synechocystis to form an aggregate, which can effectively solve the problem of inactivation or reduced activity of probiotics after oral administration through the stomach caused by various physiological challenges, thereby causing low colonization efficiency in the intestine, and inhibiting the growth and proliferation of harmful bacteria, restoring and rebuilding the intestinal barrier, regulating the intestinal flora, and thus achieving effective prevention and treatment of inflammatory bowel disease and colitis-related colitis, with a simple preparation method, low production cost and stable gastric acid environment. By incorporating different types of probiotics during the mineralization process, protective delivery of different types of probiotics can be achieved, which can not only protect probiotics from damage by gastric acid, but also promote the exponential growth and rapid colonization of probiotics in the intestine, regulate intestinal flora, and enhance the intestinal barrier, providing new technical support for the treatment of inflammatory bowel disease, and is an innovation in oral microecological preparations with huge economic and social benefits.
Claims
1. A method for preparing probiotic-Synechocystis aggregates for oral probiotic delivery, characterized in that: The following steps are involved: (1) Cultivating probiotics: inoculate the probiotic freeze-dried powder into a nutrient broth liquid culture medium, place it in a constant temperature incubator at 37-38°C, and culture it at a shaking speed of 180-200 r / min. When the proliferating reaches the logarithmic growth phase, collect the bacterial liquid for later use; The probiotics are Bacillus subtilis, Escherichia coli or Lactobacillus reuteri; The nutrient broth liquid culture medium: 0.3g beef extract, 1g peptone and 0.5g NaCl are dissolved in 90mL distilled water, the pH is adjusted to 7.0-7.4, the volume is fixed to 100mL, sterilized at 121°C for 30min, and cooled to room temperature; (2) Cultivating Synechocystis: Inoculate the Synechocystis algae in a liquid culture medium, place it in a constant temperature and light incubator at 25-30°C, and culture it under conditions of 12 hours of light and 12 hours of darkness to simulate day and night alternation. When the Synechocystis algae proliferates to the logarithmic phase, collect the algae liquid for later use; The liquid culture medium: 15g NaNO3, 2g K2HPO4, 3.75g MgSO4·7H2O, 1.8g CaCl2·2H2O, 0.3g citric acid, 0.3g ferric citrate ammonium, 0.05g EDTANa2, 1g Na2CO3, 0.286g H3BO3, 0.186g MnCl2·4H2O, 0.022g ZnSO4·7H2O, 0.039g Na2Mo4.2H2O, 0.008g CuSO4. 5H2O, 0.005g Co(NO3)2.6 H2O are dissolved in 50L ultrapure water, and filtered with a 0.22 micron filter membrane for sterilization to obtain the culture medium; (3) Preparation of biomimetic modified Synechocystis SP-PDADMAC: Take 5-15 mL of the Synechocystis solution obtained in step (2) and the algal cell concentration is OD 680 =0.8~1, centrifuged at 5000g for 5~10min, collected the precipitate, washed 3 times with 5~20mL NaCl solution to remove the residual culture medium, and obtained Synechocystis cells; the surface of Synechocystis cells is negatively charged and can be positively modified, and the cationic polyelectrolyte polydiallyldimethylammonium chloride PDADMAC molecules contain positively charged quaternary amines, which are modified on the surface of Synechocystis to modify it; Synechocystis cells are taken, resuspended with 5~50ml PDADMAC solution, placed in an incubator, and incubated at an oscillation speed of 80~100r / min for 30~60min to allow PDADMAC to be fully adsorbed on the surface of Synechocystis cells, centrifuged at 5000g for 5~10min, collected the precipitate, washed with ultrapure water, and resuspended to 1~2mL to obtain biomimetic modified Synechocystis SP-PDADMAC; The NaCl solution: 0.9 g NaCl was dissolved in 100 mL ultrapure water and mixed thoroughly to obtain a 0.9% NaCl solution; The PDADMAC solution: 1-5 mL of PDADMAC with a weight concentration of 20% is dissolved in 245 mL of sterile physiological saline, and mixed thoroughly to obtain a 1 g / L PDADMAC solution; (4) Preparation of probiotic bacteria-Synechocystis aggregates ASP@BS: 1-3 mL of the probiotic bacterial solution obtained in step (1) with a bacterial solution concentration of OD600 = 0.8-1 was taken, centrifuged at 5000 g for 5-10 min, the precipitate was collected, and washed three times with 5-20 mL of NaCl solution to remove the residual culture medium, thereby obtaining probiotic cells; The obtained probiotic cells are resuspended in 5-20 mL of sodium silicate solution, and then the biomimetic modified Synechocystis SP-PDADMAC solution obtained in step (3) is added dropwise into the sodium silicate solution, placed in a round-bottom flask, and stirred with a magnetic stirrer for 30-60 min to obtain probiotic-Synechocystis aggregates; The sodium silicate solution is prepared by dissolving 5-20 mg Na2SiO3 in 9 mL PBS phosphate buffer, adjusting the pH to 7-7.4 with 0.1 M HCl solution, and then making the volume to 10 mL.
2. The method for preparing probiotic-Synechocystis aggregates for oral probiotic delivery according to claim 1, characterized in that: The following steps are involved: (1) Cultivating probiotics: inoculate the freeze-dried powder of Bacillus subtilis into a nutrient broth liquid culture medium, place it in a constant temperature incubator at 37°C, and culture it at a shaking speed of 200 r / min. When the proliferation reaches the logarithmic growth phase, collect the bacterial liquid for later use; (2) Cultivating Synechocystis: inoculate the Synechocystis algae in a liquid culture medium, place it in a constant temperature and light incubator at 25°C, and culture it under conditions of 12 hours of light and 12 hours of darkness to simulate day and night alternation. When the Synechocystis algae proliferates to the logarithmic phase, collect the algae liquid for later use; (3) Preparation of biomimetic modified Synechocystis SP-PDADMAC: Take 5 mL of the Synechocystis solution obtained in step (2) and the algal cell concentration is OD 680 = 1, centrifuged at 5000 g for 5 min, collected the precipitate, and washed three times with 20 mL of NaCl solution to remove the residual culture medium, thereby obtaining Synechocystis cells; The surface of Synechocystis cells is negatively charged and can be positively modified. The cationic polyelectrolyte polydiallyldimethylammonium chloride (PDADMAC) molecule contains a positively charged quaternary amine, which is modified on the surface of Synechocystis to modify it. Synechocystis cells are taken, resuspended with 10 mL of PDADMAC solution, placed in an incubator, and incubated for 60 minutes at a shaking speed of 80 r / min to allow PDADMAC to be fully adsorbed on the surface of Synechocystis cells. The cells are centrifuged at 5000 g for 5 minutes, the precipitate is collected, washed with ultrapure water, and resuspended to 1 mL to obtain the biomimetic modified Synechocystis SP-PDADMAC. (4) Preparation of Bacillus subtilis-Synechocystis aggregates ASP@BS: 1 mL of the Bacillus subtilis bacterial solution obtained in step (1) with a bacterial concentration of OD600 = 1 was taken and centrifuged at 5000 g for 5 min. The precipitate was collected and washed three times with 20 mL of NaCl solution to remove the residual culture medium, thereby obtaining Bacillus subtilis cells; The obtained Bacillus subtilis cells were resuspended in 5 mL of sodium silicate solution, and then the biomimetic modified Synechocystis SP-PDADMAC solution obtained in step (3) was added dropwise into the sodium silicate solution, placed in a round-bottom flask, and stirred with a magnetic stirrer for 40 minutes to obtain Bacillus subtilis-Synechocystis aggregates.
3. The method for preparing probiotic-Synechocystis aggregates for oral probiotic delivery according to claim 1, characterized in that: The following steps are involved: (1) Cultivating probiotics: inoculate the freeze-dried powder of Escherichia coli into a nutrient broth liquid culture medium, place it in a constant temperature incubator at 37°C, and culture it at a shaking speed of 180 r / min. When the proliferation reaches the logarithmic growth phase, collect the bacterial liquid for later use; (2) Cultivating Synechocystis: Inoculate the Synechocystis algae in a liquid culture medium, place it in a constant temperature and light incubator at 28°C, and culture it under conditions of 12 hours of light and 12 hours of darkness to simulate day and night alternation. When the Synechocystis algae proliferates to the logarithmic phase, collect the algae liquid for later use; (3) Preparation of biomimetic modified Synechocystis SP-PDADMAC: Take 10 mL of the Synechocystis solution obtained in step (2) and the algal cell concentration is OD 680 = 0.9, centrifuged at 5000 g for 8 min, collected the precipitate, and washed three times with 15 mL of NaCl solution to remove the residual culture medium, thereby obtaining Synechocystis cells; The surface of Synechocystis cells is negatively charged and can be positively modified. The cationic polyelectrolyte polydiallyldimethylammonium chloride (PDADMAC) molecule contains a positively charged quaternary amine, which is modified on the surface of Synechocystis to modify it. Synechocystis cells are taken, resuspended with 50 mL of PDADMAC solution, placed in an incubator, and incubated at a shaking speed of 90 r / min for 45 minutes to allow PDADMAC to be fully adsorbed on the surface of Synechocystis cells. The cells are centrifuged at 5000 g for 8 minutes, the precipitate is collected, washed with ultrapure water, and resuspended to 1 mL to obtain the biomimetic modified Synechocystis SP-PDADMAC. (4) Preparation of probiotic bacteria-Synechocystis aggregates ASP@EcN: 2 mL of the Escherichia coli bacterial solution obtained in step (1) with a bacterial solution concentration of OD600 = 0.9 was taken and centrifuged at 5000 g for 8 min. The precipitate was collected and washed three times with 15 mL of NaCl solution to remove residual culture medium to obtain Escherichia coli cells. The obtained Escherichia coli cells were resuspended in 5 mL of sodium silicate solution. Subsequently, the biomimetic modified Synechocystis SP-PDADMAC solution obtained in step (3) was added dropwise to the sodium silicate solution, and the mixture was placed in a round-bottom flask and stirred with a magnetic stirrer for 30 min to obtain Escherichia coli-Synechocystis aggregates.
4. The method for preparing probiotic-Synechocystis aggregates for oral probiotic delivery according to claim 1, characterized in that: The following steps are involved: (1) Cultivating probiotics: inoculate the freeze-dried powder of Lactobacillus reuteri into a nutrient broth liquid culture medium, place it in a constant temperature incubator at 38°C, and culture it at a shaking speed of 180 r / min. When the proliferating reaches the logarithmic growth phase, collect the bacterial liquid for later use; (2) Cultivating Synechocystis: Inoculate the Synechocystis algae in a liquid culture medium, place it in a constant temperature and light incubator at 30°C, and culture it under conditions of 12 hours of light and 12 hours of darkness to simulate day and night alternation. When the Synechocystis algae proliferates to the logarithmic phase, collect the algae liquid for later use; (3) Preparation of biomimetic modified Synechocystis SP-PDADMAC: Take 15 mL of the Synechocystis solution obtained in step (2) and the algal cell concentration is OD 680 = 0.8, centrifuged at 5000 g for 10 min, collected the precipitate, and washed three times with 10 mL of NaCl solution to remove the residual culture medium, thereby obtaining Synechocystis cells; The surface of Synechocystis cells is negatively charged and can be positively modified. The cationic polyelectrolyte polydiallyldimethylammonium chloride (PDADMAC) molecules contain a positively charged quaternary amine, which is modified on the surface of Synechocystis to modify it. Synechocystis cells are taken, resuspended with 30 ml of PDADMAC solution, placed in an incubator, and incubated for 35 minutes at a shaking speed of 100 r / min to allow PDADMAC to be fully adsorbed on the surface of Synechocystis cells. The cells are centrifuged at 5000 g for 5 minutes, the precipitate is collected, washed with ultrapure water, and resuspended to 2 ml to obtain biomimetic modified Synechocystis SP-PDADMAC. (4) Preparation of probiotic bacteria-Synechocystis aggregates ASP@LR: 3 mL of the Lactobacillus reuteri culture solution obtained in step (1) with a culture solution concentration of OD600 = 0.8 was taken and centrifuged at 5000 g for 10 min. The precipitate was collected and washed three times with 10 mL of NaCl solution to remove the residual culture medium and obtain Lactobacillus reuteri cells; The obtained Lactobacillus reuteri cells were resuspended in 10 mL of sodium silicate solution, and then the biomimetic modified Synechocystis SP-PDADMAC solution obtained in step (3) was added dropwise into the sodium silicate solution, placed in a round-bottom flask, and stirred with a magnetic stirrer for 50 min to obtain Lactobacillus reuteri-Synechocystis aggregates.
5. Use of the probiotic-Synechocystis aggregates for oral probiotic delivery prepared by the method according to any one of claims 1 to 4 in the preparation of drugs for preventing and treating inflammatory bowel disease.
